FDA Evaluating 3 Side Effects Reported for Weight Loss Drugs
The FDA is looking into reports of potential side effects such as hair loss, aspiration, and suicidal thoughts associated with popular diabetes and weight loss drugs, Ozempic, Wegovy, Mounjaro, and Zepbound. These GLP-1 receptor agonists are used to treat diabetes and weight management. An investigation by the FDA does not mean they have concluded a…